Photobiomodulation is a novel concept in treating retinal disease.
It involves using a device to deliver low-level light to specific areas of the retina to stimulate cellular response.
The primary endpoint was a statistically significant enhancement in best corrected visual acuity (BCVA) in the PBM group compared to the control group.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.